SQLite Web: event_store.db

Update row sig_c057ef343bf1 in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000009.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000009.txt","company":"STAAR SURGICAL CO","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000009.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_2a739bbe88c802e1","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000009.txt","content_type":"text/plain","enriched_at":"2026-04-09T17:05:59.669474+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"8-K","final_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000009.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000009.txt","source_event_id":"evt_5058270198a0","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"43bf85a650636b9d","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.86,"dates_mentioned":["2026-04-08","2026-04-03","2026-05","2026-04-09"],"entities":[{"asset_class":"equity","name":"STAAR Surgical Company","relevance":"high","symbol":"STAA","type":"issuer"},{"asset_class":"person","name":"Deborah Andrews","relevance":"medium","symbol":"","type":"executive"},{"asset_class":"event","name":"ASCRS Annual Meeting","relevance":"low","symbol":"","type":"event"},{"asset_class":"exchange","name":"NASDAQ","relevance":"low","symbol":"STAA","type":"exchange"}],"event_type":"earnings","information_gaps":["What specifically changed versus the prior known state is not provided in the signal text (no prior baseline figures or prior disclosures are included).","The press release excerpt is truncated after the quoted statement (\u201csaid Deborah Andrews, In\u201d), so additional preliminary metrics (e.g., adjusted EBITDA amount, segment details) are not fully available in the provided text.","No full-quarter financial results are included; only preliminary net sales expectations are stated."],"key_facts":["Form type: 8-K (Current Report) filed for the date of report April 8, 2026; earliest event reported: April 8, 2026.","Item 7.01: On April 8, 2026, the Company issued a press release reporting selected preliminary financial results for the first quarter ended April 3, 2026; the press release is furnished as Exhibit 99.1.","The Company expects to report its full first quarter financial results in early May 2026.","Exhibit 99.1: Press release dated April 8, 2026 titled \u201cSTAAR Surgical Announces Preliminary Net Sales for First Quarter 2026.\u201d","Preliminary net sales for the first quarter of 2026 are expected to be in excess of $90 million.","For comparison, net sales for the first quarter of 2025 were $42.6 million.","The press release states the Company expects higher net sales and a significantly improved cost structure to drive a meaningful improvement in adjusted EBITDA for the first quarter.","The press release indicates the Company is announcing preliminary net sales in advance of its quarterly earnings announcement due to expected interactions with the investment community and ophthalmology community at the ASCRS Annual Meeting in Washington, D.C."],"numeric_claims":[{"label":"Expected Q1 2026 net sales","value":"in excess of $90 million"},{"label":"Q1 2025 net sales","value":"$42.6 million"}],"primary_claim":"STAAR Surgical expects first-quarter 2026 net sales to be in excess of $90 million, compared with $42.6 million for the first quarter of 2025.","relevance_score":0.78,"sentiment":"positive","source_quality":"high","summary":"STAAR Surgical filed an 8-K on April 8, 2026 to furnish a Regulation FD disclosure and attach a press release with preliminary first-quarter 2026 net sales results. The company expects to report full first-quarter financial results in early May 2026.","topics":["Form 8-K","Regulation FD disclosure","preliminary financial results","preliminary net sales","first quarter 2026","earnings timeline","Exhibit 99.1"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 STAAR SURGICAL CO \u00b7 Filed 20260408","ticker":"STAA","tickers":["STAA"],"title":"STAA filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/718937/0000718937-26-000009.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel